This might be explained by a lack of relationships between plasmatic tPA and brain amyloid in AD patients, the gap between plasma tPA level and brain tPA activity (see also below), and/or the lack of statistical power associated with the low proportion of CUA with significant amount of amyloid in their brain (i.e. 12.2 %). This evidence concerns the gene PLAT and Alzheimer disease.